| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |